High-titre GAD antibodies are found in <4% of patients with focal epilepsy62–65; interestingly, these epilepsies occur more frequently in females, arise mostly in the temporal lobe, are pharmacoresistant and are frequently associated with other autoimmune diseases like T1DM. Here, GAD1 is linked to type 1 diabetes mellitus.